Acetyl tetrapeptide-5 structure
|
Common Name | Acetyl tetrapeptide-5 | ||
|---|---|---|---|---|
| CAS Number | 820959-17-9 | Molecular Weight | 492.486 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 1237.3±65.0 °C at 760 mmHg | |
| Molecular Formula | C20H28N8O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 702.1±34.3 °C | |
Use of Acetyl tetrapeptide-5Acetyl tetrapeptide-5 inhibits glycosylation and ACE-1 activity. Acetyl tetrapeptide-5 reduces edema and relieves vascular pressure by improving the vascular system and strengthening the skin under the eyes. Acetyl tetrapeptide-5 can be used in the research of Antioxidant, anti-aging skin care[1][2][3]. |
| Name | (2S)-2-[[(2S)-2-[[(2S)-2-(3-acetamidopropanoylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Acetyl tetrapeptide-5 inhibits glycosylation and ACE-1 activity. Acetyl tetrapeptide-5 reduces edema and relieves vascular pressure by improving the vascular system and strengthening the skin under the eyes. Acetyl tetrapeptide-5 can be used in the research of Antioxidant, anti-aging skin care[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
ACE-1[1] |
| In Vitro | Acetyl tetrapeptide-5 (100 μg/mL) inhibits angiotensin-converting enzyme 1 (ACE-1) activity[1]. |
| References |
[2]. Lijuan Zhang, et al. Cosmeceuticals and peptides. Clin Dermatol. 2009 Sep-Oct;27(5):485-94. |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 1237.3±65.0 °C at 760 mmHg |
| Molecular Formula | C20H28N8O7 |
| Molecular Weight | 492.486 |
| Flash Point | 702.1±34.3 °C |
| Exact Mass | 492.208099 |
| PSA | 245.25000 |
| LogP | -3.79 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.611 |
| Storage condition | 2-8℃ |
| N-Acetyl-β-alanyl-L-histidyl-L-seryl-l-histidin |
| UNII-Y1DFQ308G8 |
| Eyeseryl |
| L-Histidine, N-acetyl-β-alanyl-L-histidyl-L-seryl- |
| N-Acetyl-β-alanyl-L-histidyl-L-seryl-L-histidine |
| Acetyl tetrapeptide-5 |